BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 21873599)

  • 1. Head and neck rhabdomyosarcoma: a critical analysis of population-based incidence and survival data.
    Turner JH; Richmon JD
    Otolaryngol Head Neck Surg; 2011 Dec; 145(6):967-73. PubMed ID: 21873599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing adult and pediatric rhabdomyosarcoma in the surveillance, epidemiology and end results program, 1973 to 2005: an analysis of 2,600 patients.
    Sultan I; Qaddoumi I; Yaser S; Rodriguez-Galindo C; Ferrari A
    J Clin Oncol; 2009 Jul; 27(20):3391-7. PubMed ID: 19398574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rhabdomyosarcoma in children: a SEER population based study.
    Perez EA; Kassira N; Cheung MC; Koniaris LG; Neville HL; Sola JE
    J Surg Res; 2011 Oct; 170(2):e243-51. PubMed ID: 21529833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Merkel cell carcinoma: identification of prognostic factors unique to tumors located in the head and neck based on analysis of SEER data.
    Smith VA; Camp ER; Lentsch EJ
    Laryngoscope; 2012 Jun; 122(6):1283-90. PubMed ID: 22522673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor location is an independent prognostic factor in head and neck Merkel cell carcinoma.
    Smith VA; MaDan OP; Lentsch EJ
    Otolaryngol Head Neck Surg; 2012 Mar; 146(3):403-8. PubMed ID: 22166964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parameningeal rhabdomyosarcoma: outcomes and opportunities.
    Yang JC; Wexler LH; Meyers PA; Wolden SL
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):e61-6. PubMed ID: 23021437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric head and neck rhabdomyosarcoma: An analysis of treatment and survival in the United States (1975-2016).
    Darwish C; Shim T; Sparks AD; Chillakuru Y; Strum D; Benito DA; Monfared A
    Int J Pediatr Otorhinolaryngol; 2020 Dec; 139():110403. PubMed ID: 33049553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term survival probabilities for childhood rhabdomyosarcoma. A population-based evaluation.
    Punyko JA; Mertens AC; Baker KS; Ness KK; Robison LL; Gurney JG
    Cancer; 2005 Apr; 103(7):1475-83. PubMed ID: 15712283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of female pediatric patients diagnosed with genital tract rhabdomyosarcoma based on analysis of cases registered in SEER database between 1973 and 2006.
    Kirsch CH; Goodman M; Esiashvili N
    Am J Clin Oncol; 2014 Feb; 37(1):47-50. PubMed ID: 23111355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors and surgical treatment guidelines for children with rhabdomyosarcoma of the perineum or anus: a report of Intergroup Rhabdomyosarcoma Studies I through IV, 1972 through 1997.
    Blakely ML; Andrassy RJ; Raney RB; Anderson JR; Wiener ES; Rodeberg DA; Paidas CN; Lobe TE; Crist WM;
    J Pediatr Surg; 2003 Mar; 38(3):347-53. PubMed ID: 12632347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population-based analysis of prognostic indicators in sebaceous carcinoma of the head and neck.
    Thomas WW; Fritsch VA; Lentsch EJ
    Laryngoscope; 2013 Sep; 123(9):2165-9. PubMed ID: 23670399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in childhood rhabdomyosarcoma incidence and survival in the United States, 1975-2005.
    Ognjanovic S; Linabery AM; Charbonneau B; Ross JA
    Cancer; 2009 Sep; 115(18):4218-26. PubMed ID: 19536876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical and prognostic analysis of single-center multidisciplinary treatment for rhabdomyosarcoma in children].
    Xu N; Duan C; Jin M; Zhang DW; Su Y; Yu T; He LJ; Fu LB; Zeng Q; Wang HM; Zhang WP; Ni X; Ma XL
    Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):767-773. PubMed ID: 31594063
    [No Abstract]   [Full Text] [Related]  

  • 14. Prognostic factors in head and neck rhabdomyosarcoma.
    Simon JH; Paulino AC; Smith RB; Buatti JM
    Head Neck; 2002 May; 24(5):468-73. PubMed ID: 12001077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The incidence and impact of comorbidity diagnosed after the onset of head and neck cancer.
    Yung KC; Piccirillo JF
    Arch Otolaryngol Head Neck Surg; 2008 Oct; 134(10):1045-9. PubMed ID: 18936348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is sex an independent prognostic factor in cutaneous head and neck melanoma?
    Arce PM; Camilon PR; Stokes WA; Nguyen SA; Lentsch EJ
    Laryngoscope; 2014 Jun; 124(6):1363-7. PubMed ID: 24122966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bladder malignancies in children aged <18 years: results from the Surveillance, Epidemiology and End Results database.
    Alanee S; Shukla AR
    BJU Int; 2010 Aug; 106(4):557-60. PubMed ID: 20015324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiologic evidence of superior outcomes for extramedullary plasmacytoma of the head and neck.
    Gerry D; Lentsch EJ
    Otolaryngol Head Neck Surg; 2013 Jun; 148(6):974-81. PubMed ID: 23482476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adult rhabdomyosarcoma: outcome following multimodality treatment.
    Little DJ; Ballo MT; Zagars GK; Pisters PW; Patel SR; El-Naggar AK; Garden AS; Benjamin RS
    Cancer; 2002 Jul; 95(2):377-88. PubMed ID: 12124838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group.
    Meza JL; Anderson J; Pappo AS; Meyer WH;
    J Clin Oncol; 2006 Aug; 24(24):3844-51. PubMed ID: 16921036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.